High mobility group box 1 (HMGB1) mediates high-glucose-induced calcification in vascular smooth muscle cells of saphenous veins

Inflammation. 2013 Dec;36(6):1592-604. doi: 10.1007/s10753-013-9704-1.

Abstract

Diabetes accelerates saphenous vein grafts calcification after years of coronary artery bypass grafting (CABG) surgery. Vascular smooth muscle cells (VSMC) undergoing a phenotypic switch to osteoblast-like cells play a key role in this process. The receptor for advanced glycation and products (RAGE) and toll-like receptors (TLRs) are all involved in various cardiovascular calcification processes. Therefore, the role of their common ligand, high mobility group box 1 (HMGB1), in high-glucose-induced calcification in VSMC of saphenous vein was investigated. In this study, VSMC were cultured from saphenous vein of patients arranged for CABG. We first demonstrated high-glucose-induced HMGB1 translocation from nucleus to cytosol, and this translocation was induced through a NADPH oxidase and PKC-dependent pathway. We next found high glucose also increased TLR2, TLR4, and RAGE expression. Then, we revealed downregulating HMGB1 expression abolished high-glucose-induced calcification accompanied by NFκB inactivation and low expression of bone morphogenetic protein-2 (BMP-2). We further demonstrated NFκB activation was necessary in high-glucose-induced BMP-2 expression and calcification. Finally, by using a chromatin immunoprecipitation assay, we demonstrated NFκB transcriptional regulation of BMP-2 promoter was induced by NFκB binding to its κB element on the BMP-2 promoter. Our findings thus suggest HMGB1 plays an important role in mediating the calcification process induced by high glucose through NFκB activation and BMP-2 expression in VSMC of saphenous vein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus
  • Bone Morphogenetic Protein 2 / biosynthesis
  • Bone Morphogenetic Protein 2 / genetics
  • Cells, Cultured
  • Coronary Artery Bypass / adverse effects
  • Diabetes Mellitus
  • Enzyme Activation
  • Glucose / metabolism*
  • HMGB1 Protein / biosynthesis
  • HMGB1 Protein / metabolism*
  • Humans
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / metabolism*
  • NF-kappa B / metabolism
  • Promoter Regions, Genetic
  • Receptor for Advanced Glycation End Products / biosynthesis
  • Saphenous Vein / metabolism*
  • Signal Transduction
  • Toll-Like Receptor 2 / biosynthesis
  • Toll-Like Receptor 4 / biosynthesis
  • Vascular Calcification / metabolism*

Substances

  • BMP2 protein, human
  • Bone Morphogenetic Protein 2
  • HMGB1 Protein
  • HMGB1 protein, human
  • NF-kappa B
  • Receptor for Advanced Glycation End Products
  • TLR2 protein, human
  • TLR4 protein, human
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • Glucose